Clinical Picture and Liver Fibrosis Based on Fib-4 in Chronic Hepatitis B Patients at Waled Hospital in 2022-2024

Read full text Summarise with VIRAT
Authors: Rere Hastari Farma Hati, Menik Herdwiyanti, Ahmad Fariz Malvi Zamzam Zein
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic hepatitis B is a liver infection caused by the hepatitis B virus, characterized by the persistence of HBsAg for six months or more. This condition can lead to progressive liver damage, resulting in fibrosis and potentially cirrhosis if not detected early. Early identification of liver fibrosis is essential to prevent complications; therefore, non-invasive scoring systems such as the fibrosis index-4 (FIB-4) have been developed. The FIB-4 score incorporates age, platelet count, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) levels to assess fibrosis risk. This study aims to describe the clinical characteristics and liver fibrosis status based on FIB-4 scores among chronic hepatitis B patients at Waled Hospital between 2022 and 2024. This observational descriptive study used a total sampling technique, including 42 patients diagnosed with chronic hepatitis B. The results showed that most patients were male (81%) and aged 45–59 years (42.9%). A high FIB-4 score (>2.67), indicating advanced fibrosis risk, was observed in 45.2% of patients. Elevated AST levels (>50 U/L) were found in 69% of cases, while ALT levels were mostly within normal to moderately elevated ranges. A small proportion of patients had decreased platelet counts and elevated total bilirubin levels. Clinically, 66.7% of patients were symptomatic, with splenomegaly being the most common finding. In conclusion, most patients were at risk of advanced fibrosis, highlighting the importance of early assessment.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Hepatitis B Virus Studies Liver Disease and Transplantation

Publication details

Journal / source
International Journal of Social health
Volume
5
Issue
3
Pages
162–174
Publication date
28 March 2026
Language
EN